- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06849375
Corneal Endothelial Assessment After Posterior Chamber Phakic Intraocular Lens Implantation
February 26, 2025 updated by: Noha Mahmoud Abdelhameed, Sohag University
our primary aim of the work to assess the effect of phakic IOL implantation on corneal endothelium.
we also used the specular microscope to assess the corneal endothelium
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
30
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Noha M Abdelhameed, Resident
- Phone Number: +20 01005156393
- Email: mnoha0421@gmail.com
Study Contact Backup
- Name: Alahmady H Alsamman, Professor
Study Locations
-
-
-
Sohag, Egypt
- Recruiting
- Sohag University Hospital
-
Contact:
- Magdy M Amin, professor
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Our inclusion criteria include: adults 18-35 years of age, myopia ˃ 6 D , anterior chamber depth (ACD) 2.85 mm or greater , an endothelial cell count of ≥ 2000 cells/mm2 and stable refractive history within 0.5 diopter for 1 year.
Exclusion Criteria:
- anterior chamber depth from endothelium < 2.85 mm, previous or current systemic or eye disease , surgery or trauma, pregnancy and nursing.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: group who implant phakic IOL
specular microscopy examination to assess the endothelial cells before and after phakic IOL implantation
|
specular microscopy examination to assess endothelial cells before and after phakic IOL implantation
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
corneal endothelial cells assessment
Time Frame: 1 year
|
specular micrioscopy examination before and after phakic IOL implantation
|
1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Reinstein DZ, MacGregor C, Archer TJ, Gupta R, Potter JG. A review of posterior chamber phakic intraocular lenses. Curr Opin Ophthalmol. 2024 Mar 1;35(2):138-146. doi: 10.1097/ICU.0000000000001018. Epub 2023 Dec 6.
- Taneri S, Dick HB. Initial clinical outcomes of two different phakic posterior chamber IOLs for the correction of myopia and myopic astigmatism. Graefes Arch Clin Exp Ophthalmol. 2022 May;260(5):1763-1772. doi: 10.1007/s00417-021-05465-w. Epub 2021 Nov 6.
- Chaurasia S, Vanathi M. Specular microscopy in clinical practice. Indian J Ophthalmol. 2021 Mar;69(3):517-524. doi: 10.4103/ijo.IJO_574_20.
- Sridhar MS. Anatomy of cornea and ocular surface. Indian J Ophthalmol. 2018 Feb;66(2):190-194. doi: 10.4103/ijo.IJO_646_17.
- DelMonte DW, Kim T. Anatomy and physiology of the cornea. J Cataract Refract Surg. 2011 Mar;37(3):588-98. doi: 10.1016/j.jcrs.2010.12.037.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 10, 2024
Primary Completion (Estimated)
December 20, 2025
Study Completion (Estimated)
December 20, 2025
Study Registration Dates
First Submitted
February 7, 2025
First Submitted That Met QC Criteria
February 26, 2025
First Posted (Actual)
March 25, 2025
Study Record Updates
Last Update Posted (Actual)
March 25, 2025
Last Update Submitted That Met QC Criteria
February 26, 2025
Last Verified
February 1, 2025
More Information
Terms related to this study
Other Study ID Numbers
- Soh-Med--25-1-11MS
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Corneal Endothelial Cells
-
University Clinic FrankfurtEnrolling by invitationCorneal Biomechanics | Tomography | Optical Coherence Tomography | Endothelial Cells | IOP | Manifest RefGermany
-
Taipei Veterans General Hospital, TaiwanNational Yang Ming UniversityCompletedEndothelial Progenitor Cells Numbers | Endothelial Function (FMD)Taiwan
-
University of FloridaNational Aeronautics and Space Administration (NASA)CompletedMicrogravity Exposed Endothelial CellsUnited States
-
EmmecellCompletedEndothelial Dysfunction | Corneal Edema | Fuchs Dystrophy | Corneal Endothelial Dystrophy | Bullous Keratopathy | Pseudophakic Bullous Keratopathy | Corneal Endothelial Dysfunction | Fuchs Endothelial Corneal Dystrophy | Moderate Corneal Endothelial DecompensationUnited States
-
University of MinnesotaCompletedExercise Tolerance | Endothelial CellsUnited States
-
Aurion BiotechRecruitingCorneal Edema | Corneal Endothelial Dysfunction | Fuchs Endothelial Corneal Dysfunction | Pseudophakic Bullous Keratopathy (PBK)United States
-
Legacy Health SystemDevers Eye Institute; Lions Eye Bank of Oregon Vision Research Laboratory; Fischer...UnknownFuchs' Corneal Endothelial DystrophyUnited States
-
Trefoil Therapeutics, Inc.CompletedEndothelial Dysfunction | Corneal Endothelial Dystrophy | Pseudophakic Bullous Keratopathy | Fuchs Endothelial Corneal DystrophyUnited States
-
Case Western Reserve UniversityNational Eye Institute (NEI)Enrolling by invitationCorneal Endothelial Decompensation | Fuchs Endothelial Corneal DystrophyUnited States
-
Kowa Research Institute, Inc.CompletedFuchs' Endothelial Corneal DystrophyUnited States, Australia, Germany, Spain, Denmark
Clinical Trials on phakic IOL implantation
-
Minia UniversityRecruiting
-
Loay Abdulmutalib AlmusawiCompletedSafety and Suitability of ICL for Correction of Refractive Errors Without the Use of Dispersive OVDsRefractive Errors | Myopia | Hypermetropia | Myopic AstigmatismIraq
-
Bausch & Lomb IncorporatedCompleted
-
Beaver-Visitec International, Inc.CompletedCataract | Presbyopia | Lens OpacityHungary
-
yin ying zhaoCompletedCongenital CataractChina
-
Beaver-Visitec International, Inc.Alexandria UniversityCompletedCataract | Presbyopia | Lens OpacitiesEgypt
-
Beaver-Visitec International, Inc.CompletedCataract | Presbyopia | Lens OpacitiesPhilippines
-
Beaver-Visitec International, Inc.CompletedCataract | Lens OpacityHungary
-
Ifocus OyeklinikkAlcon ResearchCompletedCataract and IOL SurgeryNorway
-
Beaver-Visitec International, Inc.CompletedCataract | Presbyopia | Lens OpacitiesPhilippines